rac Mephenytoin-d3 (CAS 1185101-86-3)

rac Mephenytoin-d3 is a deuterated form of mephenytoin, an antiepileptic drug that has been extensively used in research to study drug metabolism, particularly in the context of cytochrome P450 enzyme activity. The introduction of three deuterium atoms in place of hydrogen atoms in the molecule allows for the detailed examination of isotope effects on metabolic processes. This deuterated analog is particularly valuable in pharmacokinetic studies where the use of mass spectrometry is essential for distinguishing between labeled and unlabeled compounds. The racemic mixture, consisting of both R- and S- enantiomers, is instrumental in studying stereoselective metabolism, as each enantiomer can exhibit different rates of metabolism and interactions with enzymes. Researchers often use rac Mephenytoin-d3 to investigate the role of specific cytochrome P450 isoforms, such as CYP2C19, which is known to metabolize mephenytoin. By tracking the metabolic fate of the deuterated compound, scientists can gain insights into the enzyme′s catalytic mechanisms, substrate specificity, and potential genetic variations affecting drug metabolism. Moreover, rac Mephenytoin-d3 serves as a reference standard in studies involving metabolic stability, enabling the comparison of metabolic pathways and the evaluation of drug-drug interactions in various experimental models.